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Abstract
Background: The purpose of this study was to compare DNA histograms obtained by standard
flow cytometry (FC) and high fidelity image cytometry on sections (ICS) in normal gastrointestinal
mucosa and Barrett's adenocarcinoma (BAC).
Conclusion: ICS detects DNA aneuploidy in all BAC samples while FC missed the diagnosis of
aneuploidy in 29%. In addition, ICS provides more information on HI and G2 exceeding rates.
Background
DNA ploidy determination has been proposed to be use-
ful in discriminating between benign and malignant
lesions, identifying patients at high risk for developing
dysplasia or carcinoma, monitoring neoplastic progres-
sion, and predicting outcomes and responses to treatment
of cancer [1,2]. However, DNA ploidy determination in
gastrointestinal solid tumors has not achieved general
clinical use, in part, due to the lack of reliable diagnosis of
aneuploidy [3].
DNA ploidy is determined by generating a DNA histo-
gram that depicts frequency distribution with different
DNA contents of various cells. To generate DNA histo-
grams, standard flow cytometry (FC) has been used fre-
quently in neoplastic conditions including Barrett's
esophagus associated neoplastic lesions. It has been sug-
gested that baseline DNA content abnormalities as deter-
mined by FC are important predictors of progression to
Barrett's adenocarcinoma (BAC) [4,5]. However, reliabil-
ity of FC in diagnosing aneuploidy is questionable. For
example, by standard FC, up to one third of BAC are
reported to be diploid and negative for aneuploidy [6-8].
If true, this finding would suggest that almost one third of
pre-cancer neoplastic lesions may progress to BAC with-
out showing aneuploidy. However, it is unknown
whether the negative diagnosis of aneuploidy in BAC rep-
resents a true diploid status or a false negative result
related to the technique of FC.
Two main types of errors that influence FC DNA ploidy
results are: 1) technical errors related to measurement of
DNA content of individual cells; and 2) sampling errors
due to inadequate selection of cancer cells in the study
sample. A large number of technical improvements in cell
separation and analytical techniques, over the years, have
improved the technical aspects of DNA content determi-
nation of single cells as well as analysis and interpretation
of the DNA histograms [4]. However, poor sampling of
cancer cells continues to be a major limitation of FC
ploidy analysis, because cell suspension of cancerous tis-
sue used for standard FC is a mixture of cancer cells with
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an unknown proportion of diploid non-epithelial, non-
cancer cells. Shankey [9] has pointed out that in order not
to overlook aneuploidy, it is necessary to document that
at least 20% of cells in the sample are cancer cells. How-
ever, in standard FC, proportion of cancer and non-cancer
cells in the sample remains unknown. A comparison of
standard FC and double labeled FC, using samples
enriched with cancer cells, showed that many BAC that
were diploid by standard FC were found to be aneuploid
by the double-labeled FC [10]. This observation suggests
that the high rate false negative aneuploidy by standard
FC may be due to poor selection of cancer cells in the sam-
ple.
In order to avoid sampling errors, DNA ploidy analysis
has been performed by image cytometry on tissue
imprints, cell suspensions ('cytospin' preparations) or
directly on tissue sections [11]. Imprint preparations
require fresh tissue and this technique favors selection of
abnormal, loosely distributed epithelial cells and lym-
phocytes [11]. High fidelity DNA histograms on single
dispersed cells by image cytometry provide better identifi-
cation of minor clones [12-14]. Studies on breast cancer
have shown that in addition to DNA aneuploidy,
increased cellular DNA content heterogeneity and ele-
vated 5N or 9N exceeding fraction (depending upon DI of
the G0/G1 peak) may represent 'unstable aneuploidy' that
may identify severe genomic and chromosomal instability
and progressive neoplastic lesions and provide additional
prognostic indicators [13-15]
Image cytometry on tissue sections (ICS) is designed to
study the microscopically defined cell population; only
cancer cells are included for analysis of DNA ploidy status.
DNA histograms by ICS have also been improved with
better instrumentation and software that can also detect
rare events with high fidelity [16-20]. ICS is performed on
fixed tissue sections, whereas DNA FC has usually been
performed on fresh tissue. However, FC and image cytom-
etry on dispersed cells can also be performed on fixed tis-
sues and studies have shown that use of either fresh or
archival formalin-fixed paraffin-embedded tissues with
different protocols show generally similar DNA histo-
grams [9,11,21]. The advantage of using formalin fixed
tissue is the convenience in clinical practice and the possi-
bility for studies in archival tissues.
The purpose of the present study was to compare DNA
histograms obtained by standard FC and by ICS using the
Automated Cellular Imaging System (ACIS) [18,20]on
archived, formalin-fixed BAC tissues.
Methods
The study protocol was approved by the Institutional
Review Boards of the Veterans Affairs (VA) Boston Health-
care System and the Providence VA Medical Center.
Tissues
From the database of VA Boston Health Care System and
Providence VA Medical Center, we randomly selected 17
patients with BAC who underwent surgical resection
between 1991 through 2005. The archival formalin-fixed
paraffin-embedded tissue blocks were retrieved and 42
tumor-containing blocks (1–3 different blocks per
patient) were included in this study. More than one
tumor-containing block was available in 12 patients.
Results from these blocks were also used to assess the
reproducibility of the diagnosis of DNA ploidy in differ-
ent regions of the same tumor. Another 10 archival surgi-
cal resection tissue blocks from 10 non-tumor patients,
including 5 normal stomachs and 5 normal colons, were
used as controls.
Histological evaluation
For histological confirmation, a 5 μm-thick section was
cut, hematoxylin and eosin (H&E) stained, and evaluated
by an experienced gastrointestinal pathologist (Q.H.). The
diagnosis of BAC was made when individual malignant
cells or abortive glands were seen to invade through the
basement membrane into the laminar propria, muscularis
mucosa and/or beyond [22].
Flow cytometry (FC)
Standard FC was performed according to a conventional
protocol and the manufacturer's instruction. Briefly, two
50 μm thick sections adjacent to the 5 μm-thick section,
used for histological diagnosis, were cut from tissue
blocks. Tissue sections were de-paraffinized in xylene, re-
hydrated through graded ethanol to distilled water, and
allowed to hydrate overnight at room temperature. The
tissue was then minced mechanically, filtered through a
70 μm nylon mesh, and incubated for 90 minutes at 37°C
in the 0.5% pepsin solution (Sigma Chemical Co., St.
Louis, MO, USA) at pH 1.5 with intermittent vortexing.
After incubation, the centrifuged cell pellet was re-sus-
pended in phosphate buffered saline (PBS) with 1%
bovine serum albumin (BSA), and filtered through a 53
μm mesh. After centrifugation, the cell pellet was then
fixed in 70% ethanol at 4°C for 15 minutes, under-lay-
ered with 1 ml of ice-cold calf serum, and centrifuged for
3 minutes at 300 g. The supernatant was carefully aspi-
rated and the wall of the tube was wiped out with a cotton
swab to remove any attached debris. The cell pellet was
washed in 2 ml of PBS and incubated in 125 μl of ribonu-
clease solution (Sigma Chemical Co., St. Louis, MO, USA)
at 37°C for 15 minutes. After the water bath incubation,
125 μl of the propidium iodide solution (Sigma ChemicalBMC Clinical Pathology 2008, 8:5 http://www.biomedcentral.com/1472-6890/8/5
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Co., St. Louis, MO, USA) was added and the sample was
allowed to stand at room temperature for at least 30 min-
utes before applying to FC analysis. Over 10,000 cells
were included in one test sample.
DNA content measurement was performed on the FACS
Calibur flow cytometer (Becton Dickinson, CA, USA),
which was equipped with an argon laser set at an emission
wavelength of 488 nm and daily calibrated with marked
chicken erythrocytes (The QC-particles KIT, Becton Dick-
inson, CA, USA). The computer program ModFitLT soft-
ware version 2.0, provided by the manufacturer, was used
to perform DNA ploidy analysis.
For analysis and interpretation of DNA ploidy histograms,
we followed the conventional standards described previ-
ously [9]. Information on the number of cells included in
the histogram, number of cells in the peaks, DNA index
(DI) of the cells in a peak, tissue aggregates and the coef-
ficient of variation (CV) were provided in the computer
read-out. The histograms with single diploid peaks with
DI between 0.9 and 1.1 were diagnosed as DNA diploidy,
those with an additional second peak (DI between 1.1
and 1.9, or > 2.1), were diagnosed as aneuploid, and those
with a second peak with DI between 1.9 and 2.1 and con-
taining > 6% cells were diagnosed as tetraploid [9,23].
Image cytometry on sections (ICS)
ICS was performed with the ACIS (Clarient Inc., San Juan
Capistrano, CA, USA). The system was calibrated daily
using a standard procedure to ensure proper focus, black
and white level balance for each microscope objective and
linear camera outputs. The protocol for DNA content
analysis on ICS using the ACIS was the same as that
described previously [18,20]. Briefly, a 7 μm-thick section
( ± less than 0.5%) was cut on the Leica RM2155 micro-
tome from the tissue block and stained using the Feulgen
Blue Stain kit (Clarient Inc., San Juan Capistrano CA,
USA), according to the manufacturer's instructions. The 7
μm-thick section provides information on interphase
nuclei [19]. Uniformly stained tissue sections were auto-
matically scanned into the ACIS and digital images were
stored using the ACIS-Modifit software. The area of inter-
est was identified microscopically on the H&E stained sec-
tions by the pathologist (Q.H.), and the corresponding
area on the adjacent Feulgen-stained section was identi-
fied by ACIS operators (C.Y. and X.Z.), and visualized
under 40× magnification. ACIS uses a set of image
processing algorithms known as Watershed Segmentation
to exclude touching nuclei. In these algorithms, only the
separated nuclei are chosen automatically by the ACIS or
manually chosen by the operator; nuclei that touch each
other are recognized by the ACIS through their size and
other morphometric parameters and are separated by
insertion of a single pixel-wide boundary at the point of
contact. Overlapping nuclei, nuclear debris and other arti-
facts that escaped auto-detection and removal by the sys-
tem were deleted by the operator and not used for
analysis. The digital images of nuclei of interest were
stored individually and converted into a series of pixels
that were quantified as the integrated optical density
(IOD) value, representing the DNA content and morpho-
logical features of the cells, such as size, shape, contour,
granularity and chromatin texture of the nucleus.
Fifty non-epithelial cells on the same section, including
endothelial cells, macrophages, fibroblasts, and large lym-
phocytes, were served as internal reference diploid cells,
and the mean IOD value of these cells was assigned a DI
value of 1.0, corresponding to 2C or 2N (C for copy
number of the chromosomes and N for number of copies
of the chromosomes) described in the literature [24]. Two
hundred epithelial cells in the target area were then
selected and the DI of each cell was calculated with the ref-
erence to IOD of control cells. The DNA ploidy histogram
of control and target cells was then automatically gener-
ated by the system, and the IOD range of each column in
the histogram was set as 0.3. The digital image of each
selected cell and the corresponding DI value were stored
and available for later review if necessary.
The DNA histogram obtained by ICS on ACIS was ana-
lyzed as described earlier [20]. Cases with peak DI
between 0.9 and 1.1 were diagnosed as diploid and with
peak DI > 1.1 as aneuploid. Aneuploidy was further
divided into mild (DI: 1.1–1.3), moderate (DI: 1.3–1.8)
and severe (DI > 1.8). Peaks with DI vales between 1.8 and
2.2 were also classified as tetraploid that is a specific form
of aneuploidy.
Heterogeneity index (HI) was defined as the number of
clusters of cells with IOD at 0.3 intervals in the histogram
[20]. Histograms with cells with DI > G2 values were iden-
tified. Since the G2 value depends on DI of the primary
G0/G1 peak, cells with > 5N represent G2 exceeding cells
in the histograms with the peak DI of < 1.25; and cells
with > 9N represent G2 exceeding cells for the peak DI
between 1.25 and 2.25.
Statistical analysis
All values were described as Mean ± SD. Comparison of
mean values of cytometric analysis between groups was
carried out with the one-way ANOVA test. The Chi-square
test was used to compare the relative portions of cases
with positive or negative diagnosis by two methods. Cor-
relation analyses were performed using the SPSS® for Win-
dows statistical package (SPSS Inc., Version 12.0, and
Chicago, IL, USA). The two-tailed P value of 0.05 or less
was considered significant.BMC Clinical Pathology 2008, 8:5 http://www.biomedcentral.com/1472-6890/8/5
Page 4 of 9
(page number not for citation purposes)
Results
DNA flow cytometry (FC)
A total of 10925 ± 1 054 cells were analyzed by FC in 10
mucosal controls. They showed only a diploid peak con-
taining 85 ± 7.9% (range = 71.65% – 93.15%) of cells,
with CV of 5.5 ± 1.4% (range = 3.4% – 7.5%). In BACs,
standard FC revealed three different DNA ploidy pattern,
namely, diploid, aneuploid, and tetraploid (Figures 1 and
2). The DNA diploid pattern was seen in 12/42 (29%) of
BAC samples. They included 6,096 ± 1,518 cells and the
diploid peaks contained 84.6 ± 8.0% (range = 68% –
94%) cells, with CV of 6.8 ± 2.7% (range = 3.45% –
11.13%).
Thirty out of 42 (71%) BAC samples showed a second
aneuploid or tetraploid peak, in addition to the diploid
peak. The second peak had DI values between 1.18 and
2.36. Twenty four out of 42 (57%) of BAC samples were
diagnosed aneuploid. They had a second aneuploid peak
with DI values between 1.18 and 1.9 or between 2.10 and
2.36. These histograms included 5,870 ± 1,179 cells; the
aneuploid peak contained 18.0 ± 15.8% (range = 2.3% –
50.6%) of the total cells and had the CV of 5.5 ± 2.4%
(range = 2.87% – 13.5%). Six out of 42 (14%) of BAC
were diagnosed tetraploid. They had a second tetraploid
peak containing > 6% cells with DI values between 1.9
and 2.1. These histograms included 5,716 ± 1,357 cells
and the tetraploid region included 8.6 ± 2.7% of the total
cells (range = 6.0% – 12.8%). Overall, standard FC diag-
nosed diploidy in 29%, aneuploidy in 57%, and tetra-
ploidy in 14% of BAC cases. The cell numbers included in
the BAC ploidy histograms showing diploidy, aneuploidy
or tetraploidy were not statistically different (p > 0.8).
Reproducibility of the diagnosis of DNA aneuploidy in
different regions of the same BAC tumor by standard FC
was investigated in 12 cases. The study showed that the
diagnosis of aneuploidy in different regions of the same
tumor was reproducible in 6/12 (50%) cases.
DNA ICS using ACIS
All control normal gastrointestinal mucosal samples
showed diploid peaks with DI values between 0.9 and 1.1.
The HI was 11.3 ± 1.1, and there were no cells with DI val-
ues greater than G2 or > 5N.
Concordance of DNA diploidy on standard FC and ICS in a control but not in BAC Figure 1
Concordance of DNA diploidy on standard FC and ICS in a control but not in BAC.A: Normal gastric mucosa 
shows a diploid DNA histogram on standard FC as well as on ICS. Note that the diploid peak is sharp and narrow (CV = 
4.18%) on standard FC and on ICS. There is no increased scatter of cells outside the peak. B: BAC shows a DNA diploid histo-
gram on standard FC but a DNA aneuploid histogram on ICS. The top panel shows a DNA diploid (2N) peak on flow FC. The 
bottom panel on ICS shows no diploid peak but a wide and short aneuploid peak with peak DI of 1.76, as well as cells with dif-
ferent DI values but no cells with DNA content > 9N. (X-axis shows IOD values and the vertical lines mark DI values).BMC Clinical Pathology 2008, 8:5 http://www.biomedcentral.com/1472-6890/8/5
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In contrast, the main peaks in all BAC samples were either
moderately (DI: 1.3–1.8) or severely (peak DI > 1.8) ane-
uploid. Sometimes, multiple overlapping peaks were
noted. HI was markedly elevated with a value of 32.4 ±
8.5. The difference in HI between the control and BAC
cells was statistically highly significant (p < 0.001). Cells
with DI exceeding G2 was represented by > 5N for the G0/
G1 peaks with DI < 1.25 and > 9N for those with peak DI
< 2.5. None of the BAC cases had peak DI < 1.25 but 37
cases had peak DI between 1.25 and < 2.25; 19/37 (51%)
of these histograms showed cells with DI > 9N.
There was no intra-tumor heterogeneity in aneuploidy
diagnosis by ICS as all BAC samples from different regions
of the same tumor were aneuploid. As shown in Figure 3,
there was an excellent correlation between DI values of
two different regions of the same tumor (R = 0.857, p <
0.01).
Comparison of DNA ploidy profiles between FC and ICS
As shown in Figures 1, 2 and Table 1, normal gastrointes-
tinal mucosa produced normal diploid DNA histograms
on both standard FC and ICS. However, the CV of diploid
peaks by ICS was significantly larger than that by standard
FC (15.8 ± 2.8% vs. 5.5 ± 1.4%; p < 0.05).
Standard FC diagnosed DNA diploidy in 12/42 (29%)
and aneuploidy/tetraploidy in 30/42 (71%) BAC. In con-
trast, all diploid BAC samples by FC were shown to be
aneuploid on ICS (p < 0.01) and all aneuploid BAC by FC
remained aneuploid on ICS. Moreover, the elevated 9N
exceeding fraction was seen in 19/37 (49%) of BAC sam-
ples, with peak DI between 1.25 and 2.25, by ICS but FC
did not detect 9N exceeding cells in any BAC samples.
Concordance of DNA aneuploidy/tetraploidy on standard FC and ICS in BAC Figure 2
Concordance of DNA aneuploidy/tetraploidy on standard FC and ICS in BAC.A: BAC shows a DNA aneuploid his-
togram on FC as well as on ICS. The top panel shows a DNA diploid (2N) peak and an aneuploid peak on FC. The aneuploid 
peak on standard FC had a DI value of 1.6. The bottom panel shows that on ICS, no diploid peak was seen but a broad aneu-
ploid peak with DI value of 1.69, and a large scatter of cells and some cells with DNA content > 9N (see marker for DI of 4). 
B: BAC shows a DNA tetraploid histogram on standard FC and ICS. The top panel shows a DNA diploid (2N) peak and a 
tetraploid peak on standard FC. Note that the diploid peak has a large CV (21.41%), representing a diploid with an overlapping 
paradiploid peak. The bottom panel shows, on ICS, a small diploid peak but a large broad tetraploid peak with DI value of 1.87. 
Also note a large scatter of cells with different DNA contents but no cells with DNA content > 9N (X-axis shows IOD values 
and the vertical lines mark DI values).BMC Clinical Pathology 2008, 8:5 http://www.biomedcentral.com/1472-6890/8/5
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Discussion
The results of this study in BACs show that: 1) Standard
DNA FC yields high rates of false negative results in diag-
nosing aneuploidy and produces low fidelity histograms
that overlook minor severe aneuploid clones of cells; 2) In
contrast, high fidelity DNA ICS eliminates false negative
results and produces high fidelity DNA histogram that
precisely identifies minor significant clones.
In this study, standard FC diagnosed 29% of BAC as dip-
loid. This rate of diploid BAC is similar to that reported by
others, showing that about 30% of BAC were DNA dip-
loid by FC [6,7,25]. In contrast, all BAC cases including
those diagnosed as diploid on FC were aneuploid on ICS.
It could be argued that cases of BAC found to be diploid
by FC are truly diploid and are falsely diagnosed positive
for aneuploidy by ICS. However, this is unlikely because
ICS did not yield any false positive diagnosis of aneu-
ploidy in normal control cases that were all correctly iden-
tified as diploid. Moreover, the finding of DNA
aneuploidy in all BAC samples examined by ICS is similar
to other previous reports [17,20]. These observations are
also supported by the results of comparative genomic
hybridization and karyotyping studies that show major
chromosomal alterations in almost all BAC cases [26,27].
These observations suggest that all BAC tumors are aneu-
ploid.
The false negative diagnosis of DNA aneuploidy in BAC
on FC in this study may be due to technical limitations,
such as inclusion of fewer than 10 000 cells in a DNA his-
togram. However, this is unlikely. Although greater than
10 000 cells are required for analysis of the S-phase, a
smaller number of cells are still sufficient for identifica-
tion of aneuploid peaks [9]. Moreover, in our study, the
number of tumor cells included for analysis in BAC with
diploid DNA histograms was not different from that in
BAC showing DNA aneuploid or tetraploid histograms.
The main reason for the false negative aneuploidy result
in BAC by standard FC appears to be the inclusion of dis-
proportionately large number of non-cancerous diploid
cells in the samples. This view is supported by the studies
of Rickes and colleagues [10] who reported that many
cases of esophageal squamous cell carcinoma or adeno-
carcinoma that were diploid on standard FC were aneu-
ploid by the double-labeled FC in which esophageal
cancer cells were labeled with cytokeratin-19 for squa-
mous cell carcinoma and cytokeratin-18 for adenocarci-
noma [10]. Similarly, all cases of BAC were found to be
aneuploid by image cytometry that performs DNA con-
tent analysis on identified abnormal cells [17,20]. These
results are also similar to those on breast cancer, in which
many breast carcinomas diagnosed as diploid by FC were
aneuploid by ICS [28,29].
Because of the high false negative rate, DNA aneuploidy
diagnosis by standard FC was not reproducible in differ-
ent regions of the same BAC, as shown in this study,
Correlation of DI values on ICS between two different tissue  blocks from the same BAC Figure 3
Correlation of DI values on ICS between two differ-
ent tissue blocks from the same BAC. Note that there 
is a good correlation between the DI values of the aneuploid 
peaks in tissues from two sites of the same BAC.
Table 1: Comparison of DNA ploidy status in normal mucosa and BACs generated with FC and ICS
DNA ploidy status Normal mucosa BAC
FC ICS FC ICS
Cases with Diploidy 100% 100% 29% 0
Cases with aneuploidy/tetraploidy 0 0 71% 100%
Heterogeneity Index (mean ± SD) -- 11.3 ± 1.1 -- 32.4 ± 8.5
Cases with elevated G2 exceeding fraction (9N)* -- 0 -- 51%
Total 10 10 42 42
*Elevated > G2 exceeding fraction include cases showing cells with DI > 9N in the histograms with peak DI between > 1.25 and < 2.25 that was 
seen in 19 out of 37 cases.BMC Clinical Pathology 2008, 8:5 http://www.biomedcentral.com/1472-6890/8/5
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resulting in false diagnosis of tumor heterogeneity. Simi-
lar findings have been reported in breast carcinoma
[30,31]. The lack of reproducibility of DNA aneuploidy
diagnosis by standard FC was previously thought to be
due to intra-tumor heterogeneity and studies on multiple
samples have been recommended for proper evaluations
of DNA aneuploidy in BAC [30,31]. However, the present
study shows that by ICS all regions of a BAC were aneu-
ploid, which supports the notion that tissue sampling
may affect diagnosis of DNA ploidy by standard FC but
not by ICS. These results are similar to those reported in
breast carcinoma, suggesting that the reported intra-
tumor DNA ploidy heterogeneity was due to differences in
the techniques used for DNA ploidy analysis [30].
DNA FC technique uses dispersed cell from the whole tis-
sue. Studies using dispersed cells are subject to artifact dis-
tortions related to the quality of cell dispersal that
determines the amount of cellular debris and aggregates,
which affect the DNA histograms[9]. Moreover, unse-
lected dispersed cells from tissues represent mixed popu-
lations of abnormal cells (cells of interest) and non-
epithelial cells. The proportion of abnormal epithelial
and non-epithelial cells varies with the source (e.g., super-
ficial mucosal biopsy vs. deep surgical section) and the
cellular composition of the tissue [10]. Therefore, studies
on unselected dispersed cells are highly dependent on tis-
sue selection. The instruments and analytical methods
used for DNA histogram construction and the criteria for
diagnosis of aneuploidy may also affect the results. Inter-
laboratory consistency and reproducibility of the FC
results have been improved over the years with the devel-
opment of standardized cell dispersion methods, quality
control measures, and improved analytical statistical
packages [4,32].
The DNA histograms by FC are biased towards major
peaks at the cost of minor peaks and show dominant dip-
loid peaks in all cancer cases [15]. The dominant diploid
peaks in FC of BAC may represent contaminated non-can-
cerous cells in the sample. Because of the bias towards the
large peaks, minor but significant peaks and individual
severe aneuploid cells are ignored and masked by the
background noise in the FC-histograms. Therefore, stand-
ard FC does not faithfully detect DNA content heterogene-
ity or scattering of cells in the histogram.
In contrast to FC, high fidelity ICS identified all BAC tis-
sues as aneuploid and the histograms showed lack of dip-
loid peaks as also reported previously [10,17]. The main
reason for these findings may be related to the fact that in
ICS selected tumor cells, primarily, are included for DNA
content analysis. Moreover, these histograms also identify
each cell including the minor aneuploid clones in the his-
togram and provide an excellent estimate cellular DNA
content heterogeneity and G2 exceeding fractions [20].
Another advantage of this technique is that the tissue sec-
tions tested as well as the image of each cell and its esti-
mated DNA content are stored in the ACIS system for
future verification when needed.
However, ICS has some potential limitations in nuclear
DNA content determination related to thickness of the
sections [33]. Thick sections (~15 μm) may present many
overlapping nuclei of adjacent cells resulting in overesti-
mation of DNA content [19], whereas, thin sections (4 μm
– 5 μm) lead to truncated nuclei resulting in underestima-
tion of the DNA content. Such thin sections require the
use of correction factors to compensate for the underesti-
mate [16]. Thus, estimation of nuclear DNA values on sec-
tions may be sufficiently precise only if the thickness of
each individual section is known and the nuclear IOD-
values have mathematically been corrected for the error
caused by different thickness of sections [33]. This techni-
cal challenge has been mitigated to some extent by obtain-
ing uniform sections of 7 μm to 8 μm sections that yield
optimal results for study of interphase nuclei [11,19]. The
ACIS uses a set of image processing algorithms known as
Watershed Segmentation to exclude touching nuclei
[18,20]. Overlapping nuclei, nuclear debris, and other
artifacts that escape auto-detection and removal by the
ACIS are edited out by the operator.
Another potential problem in ICS is operator bias in
selecting 'cells of interest'. Selection of abnormal cancer
cells may lead to a positive aneuploidy result whereas
inclusion of normal epithelial cells may produce a false
negative aneuploidy result. In this study, the operator bias
was avoided by a two-step process in which the operator
was blinded to the histological diagnosis. The operator
selected all qualified artifact-free cells in the area of inter-
est that was marked by the pathologist on the adjacent
H&E stained section.
In this study DNA histograms obtained by FC and ICS
were compared in normal mucosa and BAC because their
histological diagnosis is not subject to observer variabil-
ity. These studies show that both FC and ICS faithfully
yield diploid DNA histograms in normal gastrointestinal
mucosa, but ICS identifies aneuploidy in BAC samples
that are diagnosed as diploid by FC. The high false nega-
tive rate of diagnosis of aneuploidy in BAC suggests that
FC may also underestimate aneuploid cases of Barrett's
dysplasia. Therefore, usefulness of DNA ploidy status by
standard FC in confirmation of histological diagnosis of
dysplasia or as a clinical biomarker for neoplastic progres-
sion in BAC may be limited and require reevaluation
[3,4].BMC Clinical Pathology 2008, 8:5 http://www.biomedcentral.com/1472-6890/8/5
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Studies using high fidelity ICS have shown that the fre-
quency and severity of aneuploidy by ICS progressively
increases with increasing histological grades of dysplasia
[20]. Moreover, some of these cases show DNA histo-
grams with greatly increased DNA content heterogeneity
and increased number of cells with DNA content greater
than their G2 phase, such as increased > 5N cells in the
histograms with DI of the peak < 1.25, and cells > 9N in
the histograms with DI of peak < 2.5. Increased DNA het-
erogeneity and elevated G2 exceeding fractions may be
important indicators for genomic instability and neoplas-
tic progression. ICS also has the advantage of use in clini-
cal practice as it needs only a small tissue sample and
creates a permanent record for independent verification.
All these features make ICS a highly desirable tool for
DNA ploidy determination in neoplastic conditions. Fur-
ther studies are warranted to examine the usefulness of
DNA content analysis by ICS in discriminating between
benign and malignant lesions, identifying patients at high
risk for developing dysplasia or carcinoma, monitoring
neoplastic progression, and predicting outcomes and
responses to treatment of certain types of gastrointestinal
cancer including BAC. In this study we only compared FC
and ICS. Further studies are needed that directly compare
the results of ICS with image cytometry on dispersed cell.
Conclusion
This study shows that high fidelity ICS is more sensitive
and specific than standard FC for detection of DNA aneu-
ploidy in BAC. The high false negative diagnostic rate of
DNA aneuploidy in the adenocarcinoma on FC may result
from factors such as sampling errors and dilution effects
by non-neoplastic cells. High fidelity ICS also provides
additional information relevant to neoplastic progression
such as HI and G2 exceeding rates. Moreover, this method
uses small amounts of biopsy tissues and can be easily
extended to tissue samples submitted for conventional
histopathological evaluation. A permanent record of the
data that can be easily recalled for reexamination, if
needed, further adds to usefulness of this technique in
clinical practice.
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